Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Lexicon Pharmaceuticals (LXRX) operate in?

Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.

Open	$0.74
Close	-
Volume / Avg.	1.58M / 4.89M
Day Range	$0.71 - $0.75
52 Wk Range	0.62 - 3.26
Market Cap	$256.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	26.4%
Days to Cover	7.38

Recent News

2 Generic Drug Stocks Ready to Surge in 2025

Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact duplicates of the branded counterparts, while biosimilars are "similar" and often require

MarketBeat

Crude Oil Moves Higher; Apple Shares Slide After Q4 Results

Avi Kapoor

Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.74
Close	-
Volume / Avg.	1.58M / 4.89M
Day Range	$0.71 - $0.75
52 Wk Range	0.62 - 3.26
Market Cap	$256.80M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	26.4%
Days to Cover	7.38

About Lexicon Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, developm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lexicon Pharmaceuticals (LXRX) stock?

You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.

View our list of the best stock brokerages

Who are Lexicon Pharmaceuticals (LXRX) competitors?

Other companies in Lexicon Pharmaceuticals’s space includes: Korro Bio (NASDAQ:KRRO), Monopar Therapeutics (NASDAQ:MNPR), Tango Therapeutics (NASDAQ:TNGX), Tevogen Bio Holdings (NASDAQ:TVGN) and Eledon Pharma (NASDAQ:ELDN).

What is the forecast, or price target, for Lexicon Pharmaceuticals (LXRX) stock?

Lexicon Pharmaceuticals has a consensus price target of $6.00.

What is the current price for Lexicon Pharmaceuticals (LXRX)?

The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $0.7104 last updated February 21, 2025 at 1:13 PM EST.

Does Lexicon Pharmaceuticals (LXRX) pay a dividend?

There are no upcoming dividends for Lexicon Pharmaceuticals.

When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?

Lexicon Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Lexicon Pharmaceuticals (LXRX) going to split?

There is no upcoming split for Lexicon Pharmaceuticals.

What sector and industry does Lexicon Pharmaceuticals (LXRX) operate in?

Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals (LXRX) Forecast